On November 13, Gelonhui reported that Shanghai Haishun New Pharmaceutical Packaging (300501.SZ) stated at the performance briefing held on November 12, 2024, that the company's original production capacity utilization rate is relatively high, mainly focusing on the steady growth of the pharmaceutical packaging business. Currently, the company is fully promoting the release of production capacity for high barrier composite materials projects, and will disclose relevant progress in subsequent announcements.
海顺新材(300501.SZ):目前公司在全力推动高阻隔复合材料项目产能释放
shanghai haishun new pharmaceutical packaging (300501.SZ): Currently, the company is fully promoting the release of production capacity for high barrier composite materials projects.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.